Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Marc Tessier-Lavigne
Age : 61
Public asset : 55,313,009 USD
Country of residence : Unknown
Linked companies : Regeneron Pharmaceuticals, Inc. - Denali Therapeutics Inc.

Biography of Marc Tessier-Lavigne 
Dr. Marc Tessier-Lavigne is a President at Stanford University, an Independent Director at Denali Therapeutics, Inc., an Independent Director at Regeneron Pharmaceuticals, Inc., a Member at American Philosophical Society, a Member at Institute of Medicine, a Member at National Academy of Medicine of United States, a Member at National Academy of Sciences, a Member at Royal Society of Canada and a Member at The Royal Society. He is on the Board of Directors at Denali Therapeutics, Inc., Regeneron Pharmaceuticals, Inc., Federal Reserve Bank of New York, Stanford Alumni Association, The Rockefeller Archive Center and Bay Area Council Economic Institute. Dr. Tessier-Lavigne was previously employed as an Independent Director by Juno Therapeutics, Inc., an Independent Director by Pfizer Inc., a Chairman by Agios Pharmaceuticals, Inc., a President, Trustee & Professor by The Rockefeller University, a Chief Scientific Officer & Executive VP-Research by Genentech, Inc., a Founder by Renovis, Inc., and a Professor by The University of California, San Francisco. He also served on the board at The Aaron Diamond AIDS Research Center. He received his undergraduate degree from the University of Oxford, an undergraduate degree from McGill University and a doctorate degree from the University College London.


Current positions of Marc Tessier-Lavigne 
Holdings of Marc Tessier-Lavigne 
Marc Tessier-Lavigne : Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/20XAVIER NIEL : UWR shares spike as billionaire Xavier Niel discloses 27% stake
RE
05/19ELON MUSK : Musk says 'Tesla is on my mind 24/7' amid concerns about Twitter distraction
RE
05/10ELON MUSK : Elon Musk says Tesla open to buying a mining company
RE
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
05/09ELON MUSK : Musk tweet on Japan doomed by low birthrate provokes anger - but not just at him
RE
More news


© 2022 People and Ownership :   
Marc Tessier-Lavigne : Connections 


Latest news about Marc Tessier-Lavigne 
2020TRANSCRIPT : Denali Therapeutics Inc. Presents at Citi 15th Annual Biopharma Virtual Conference 2020, Sep-10-2020 03:20 PM
CI
2020TRANSCRIPT : Passage Bio, Inc. Presents at Citi 15th Annual Biopharma Virtual Conference 2020, Sep-10-2020 03:20 PM
CI
2019TRANSCRIPT : Denali Therapeutics Inc. Presents at JP Morgan 37th Annual Healthcare conference, Jan-07-2019 through Jan-10-2019
CI
2018TRANSCRIPT : Denali Therapeutics Inc. - Analyst/Investor Day
CI
2018TRANSCRIPT : Regeneron Pharmaceuticals, Inc. - Shareholder/Analyst Call
CI
2017TRANSCRIPT : Regeneron Pharmaceuticals, Inc. - Shareholder/Analyst Call
CI
2017TRANSCRIPT : Amyris, Inc. - Analyst/Investor Day
CI
More news